Philogen

Pharmaceutical Manufacturing • Monteriggioni, Tuscany, Italy • 101-200 Employees

Company overview

Headquarters	Loc. Bellaria, 35, Sovicille, SIENA 53018, IT
Phone number	+39057717816
Websites	philogen.com philogengroup.it philogen.it
NAICS	3254
SIC	283
Founded	1996
Employees	101-200
Socials

Key Contacts at Philogen

Elena Patruno

Medical Director

Giovanni Neri

Director Ip Rights

Philogen Email Formats

Philogen uses 5 email formats. The most common is {first initial}.{last name} (e.g., j.doe@philogen.com), used 45% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@philogen.com	51.1%
{first name}.{last name}	john.doe@philogen.com	46.5%
{first initial}.{second initial}{last name}	j.odoe@philogen.com	1.5%

About Philogen

Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders. Angiogenesis, i.e. the formation of new blood vessels, is a characteristic feature of many severe pathologies such as cancer, rheumatoid arthritis and age-related macular degeneration. The company has been a pioneer in the isolation, engineering and clinical development of lead products capable of targeting angiogenesis in-vivo and has been the first in the world to demonstrate that human monoclonal antibodies, specific for a marker of angiogenesis, can efficiently and selectively target the tumor neo-vasculature both in animal models and in cancer patients. At present, Philogen has four promising anti-cancer antibody derivatives and an antibody derivative for the treatment of rheumatoid arthritis in clinical studies. Two registrational studies are in planning. Our Zurich-based daughter company Philochem serving as the R&D unit isolates the most promising candidate products, while in Siena (Italy) the pharmaceuticals are produced according to GMP standards and advanced to clinical trials. Philogen generates revenue from a diversified range of activities, has signed agreements with major pharmaceutical companies and owns a diversified portfolio of international patents.

Philogen revenue & valuation

Annual revenue	$27,800,000
Revenue per employee	$168,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$88,800,000
Total funding	$69,500,000

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Entry

Manager

Director

Employees by Department

Philogen has 86 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Philogen's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-06-14	1	$69,500,000

Funding Insights

$69,500,000

Total funding amount

$69,500,000

Most recent funding amount

Number of funding rounds

Philogen Tech Stack

Discover the technologies and tools that power Philogen's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

MediaElement.js

Video players

Site Kit

Analytics

iubenda

Cookie compliance

Swiper

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Divi

Page builders

Google Analytics

Analytics

Frequently asked questions

Philogen is located in Monteriggioni, Tuscany, IT.

You can reach Philogen at +39057717816.

Philogen was founded in 1996, making it 30 years old. The company has established itself as a significant player in its industry over this time.

Philogen has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Philogen has raised a total of $69,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Philogen

Elena Patruno

Medical Director

Giovanni Neri

Director Ip Rights

4.8

40,000 users